Average Co-Inventor Count = 6.43
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Fujisawa Pharmaceutical Company, Ltd. (14 from 940 patents)
14 patents:
1. 6582351 - Imidazopyridinone derivatives and their use as phosphodiesterase inhibitors
2. 6384080 - Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
3. 6194396 - Benzimidazole compounds as bradykinin antagonists
4. 6169095 - Bradykinin antagonist quinolines
5. 6083961 - Benzimidazole compounds as bradykinin antagonists
6. 6083959 - Quinoline derivatives, processes for their preparation and their use as
7. 6069162 - Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide
8. 5994368 - Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin
9. 5932737 - Peptide compounds for treatment of no-mediated diseases
10. 5922711 - 8-substituted quinazolines, quinoxalines and benzopyridazines
11. 5708173 - Heterocyclic compounds
12. 5563162 - Bradykinin antagonist quinolines
13. 5354759 - Angiotenin II antagonizing heterocyclic compounds
14. 5210092 - Angiotensin II antagonizing heterocyclic derivatives